Since April 18, 2023, the United States Patent and Trademark Office (USPTO) has been issuing and publishing patent grants ...

There are many valuable benefits of registering one’s trademark with the United States Patent and Trademark Office (USPTO). A cursory Internet ...

Atossa Therapeutics (ATOS) announced that the United States Patent and Trademark Office has granted a new patent directed to enteric oral ...

Fifth issued patent in the U.S. for QTORIN™ rapamycin with anticipated patent life extending into 2038 QTORIN™ rapamycin has ...

The claims cover combination treatment of onvansertib + bev for all bev-naïve patients including RAS-mutated and RAS wild type mCRC across all lines of therapy through 2043SAN DIEGO, April 23, 2025 ...

Newly allowed patent extends Wearable Devices’ innovative gesture technology into the domain of voice control ...

GM has filed a patent application for a power-operated seat armrest system, potentially offering enhanced comfort for ...

Nexalin has received patent approval from the United States Patent and Trademark Office (USPTO) for its deep intracranial ...

"Clinicians in critical care are constantly balancing precision and efficiency,” said John Erb, Interim Chief Executive Officer of Nuwellis. "This patent reflects our commitment to supporting them ...

The issuance of this patent marks another key milestone as FluidForm Bio continues to build a strong and defensible IP portfolio and extend its leadership in bioprinted regenerative medicine. The ...

HOUSTON, TX, April 14, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, is ...